0001209191-14-057715.txt : 20140912 0001209191-14-057715.hdr.sgml : 20140912 20140912160845 ACCESSION NUMBER: 0001209191-14-057715 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140910 FILED AS OF DATE: 20140912 DATE AS OF CHANGE: 20140912 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anacor Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001411158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251854385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: 650-543-7500 MAIL ADDRESS: STREET 1: 1020 E. MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 FORMER COMPANY: FORMER CONFORMED NAME: Anacor Pharmaceuticals Inc DATE OF NAME CHANGE: 20070830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chanda Sanjay CENTRAL INDEX KEY: 0001571820 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34973 FILM NUMBER: 141100965 MAIL ADDRESS: STREET 1: C/O ANACOR PHARMACEUTICALS, INC. STREET 2: 1020 EAST MEADOW CIRCLE CITY: PALO ALTO STATE: CA ZIP: 94303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-09-10 0 0001411158 Anacor Pharmaceuticals, Inc. ANAC 0001571820 Chanda Sanjay C/O ANACOR PHARMACEUTICALS, INC. 1020 EAST MEADOW CIRCLE PALO ALTO CA 94303 0 1 0 0 SVP, Drug Development Common Stock 2014-09-10 4 M 0 5047 7.25 A 9042 D Common Stock 2014-09-10 4 S 0 5047 24.25 D 3995 D Common Stock 2014-09-10 4 M 0 4953 5.00 A 8948 D Common Stock 2014-09-10 4 S 0 4953 24.25 D 3995 D Stock Option (right to buy) 7.25 2014-09-10 4 M 0 5047 7.25 D 2018-03-26 Common Stock 5047 9952 D Stock Option (right to buy) 5.00 2014-09-10 4 M 0 4953 5.00 D 2019-03-26 Common Stock 4953 0 D Includes 995 shares purchased on July 31, 2014, pursuant to the Issuer's ESPP. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2014. This option is fully vested and exercisable. /s/ Lucy O. Day, as Attorney-in-fact 2014-09-12